Empirical Wealth Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $467K | Buy |
6,760
+232
| +4% | +$16K | 0.01% | 429 |
|
|
2025
Q1 | $453K | Sell |
6,528
-925
| -12% | -$64.2K | 0.01% | 421 |
|
|
2024
Q4 | $641K | Buy |
7,453
+578
| +8% | +$49.7K | 0.02% | 343 |
|
|
2024
Q3 | $819K | Buy |
6,875
+463
| +7% | +$55.1K | 0.02% | 294 |
|
|
2024
Q2 | $915K | Buy |
6,412
+1,890
| +42% | +$270K | 0.03% | 268 |
|
|
2024
Q1 | $581K | Sell |
4,522
-348
| -7% | -$44.7K | 0.02% | 323 |
|
|
2023
Q4 | $504K | Buy |
4,870
+1,608
| +49% | +$166K | 0.02% | 319 |
|
|
2023
Q3 | $297K | Buy |
+3,262
| New | +$297K | 0.01% | 370 |
|